The Effectiveness of Retinalamin® Administered by Various Intramuscular Injection Timings in the Treatment of Patients with the Dry Form of Age- Related Macular Degeneration
The paper presents the evaluation of Retinalamin efficacy administered intramuscularly to 90 patients (180 eyes) aged 47 to 75 (averagely, 65.9 ± 7.18 years) with various stages of dry age-related macular degeneration (AMD) once or twice in 6 months. The data of multifocal electroretinography (MfERG...
Autors principals: | , , , , |
---|---|
Format: | Article |
Idioma: | Russian |
Publicat: |
Real Time Ltd
2018-10-01
|
Col·lecció: | Российский офтальмологический журнал |
Matèries: | |
Accés en línia: | https://roj.igb.ru/jour/article/view/7 |